Business, energy, technology, markets and global industry news from Business News Today

Skip to content

Home
Pharma & Biotech
Medical Devices & Diagnostics
Features & Analysis

Home
Pharma & Biotech
Medical Devices & Diagnostics
Features & Analysis

Evaxion

PharmaDeviceNews Evaxion

Representative image illustrating personalized cancer vaccine research as Evaxion advances its AI-designed EVX-01 melanoma vaccine with new Phase 2 immune biomarker data.

Pharma & Biotech

EVX-01 personalized cancer vaccine moves into focus as Evaxion examines broader immune responses

by Soujanya Ravi
November 4, 2026
0 Comments

Evaxion advances EVX-01 melanoma vaccine research with new Phase 2 immune biomarker data. Explore its 75% response rate and future potential.

Read More

Latest news and features

EVX-01 personalized cancer vaccine moves into focus as Evaxion examines broader immune responses
PAS-004 advances toward Phase 2 as Pasithea seeks new treatment approach for cutaneous neurofibromas
T-Cypher Bio reports promising cancer cell killing with two next-generation T-cell engagers.
Trastuzumab pamirtecan slows breast cancer progression but raises interstitial lung disease concerns
Guardian Pharmacy Services has made another Tennessee acquisition, but can its local-first model sustain national growth?
Aarvik Therapeutics advances ARR-002 into Phase 1 and licenses two ADC candidates to Laurus Labs for India
Blackstone and Boston Scientific strike $455m VITALYST deal targeting cardiogenic shock treatment by 2030
Mirum Pharmaceuticals prepares new brelovitug, volixibat and LIVMARLI data for AASLD 2026
Gilead’s weekly HIV pill has passed Phase 3, but can fewer doses deliver better treatment adherence?
HeartBeam 3D ECG achieves 81.8% specificity in 132-patient heart attack study, beating standard ECG on one measure
Nasal foralumab reduces brain inflammation marker in Phase 2a multiple sclerosis trial
Huntington’s disease treatment milestone: uniQure secures priority FDA review for one-time gene therapy

POPULAR NEWS

plated Skin Science’s new BODY Serum brings platelet-derived exosome skincare beyond the face, targeting signs of aging, texture and hydration across the body. Representative image.

Pharma & Biotech

Rion Aesthetics expands plated Skin Science exosome platform with $338 BODY Serum

August 19, 2026

Pharma & Biotech

Omabit raises $2m to connect fragmented clinical evidence, but can AI improve drug development decisions?

October 27, 2026

Medical Devices & Diagnostics

Presage Technologies SmartSpectra cleared for contactless vital signs monitoring

July 8, 2026

Latest business and industry news

South Carolina nuclear site fire triggers emergency as officials report no radioactive contamination
Subsea7 (SUBC) wins $150m-$300m Aker BP contract for Norway’s fast-track Lyra oil development
Estée Lauder fragrance sales jump 20%. Is Beauty Reimagined finally working?
Garden Reach Shipbuilders (GRSE) signs Rs 32,000cr Navy corvette contract as shares jump 5.3%
Oracle seeks another $20bn for AI. Why did ORCL fall nearly 6%?

TAGS

AstraZeneca clinical trials Eli Lilly and Company European Medicines Agency FDA FDA approval immunotherapy Inc. Johnson & Johnson medical devices non-small cell lung cancer oncology precision oncology U.S. Food and Drug Administration United States Food and Drug Administration

About PharmaDeviceNews
Disclaimer
Editorial Policy
Privacy Policy
Contact Us

© 2026 PharmaDeviceNews.com. All rights reserved.